Protect patient safety, improve trial consistency, and reduce risk through a standardized approach to immune-related adverse event management.

Watch the Trailer:

Session Overview

Immune-based therapies have transformed cancer treatment but can cause distinct and unpredictable immune-related adverse events that require a different approach than traditional chemotherapy toxicities.

In this on-demand webinar, experts Dr. Gwyn Bebb and Dr. Salini Naidu share practical strategies for standardizing irAE management across global oncology trials. Through case studies and expert insights, they explore how early medical involvement, consistent grading, central monitoring, and effective site training can improve patient safety and trial execution.

Learn how a proactive, guideline-driven framework can reduce avoidable discontinuations, strengthen data integrity, improve site confidence, and protect the long-term viability of investigational assets.

What You’ll Learn:

How immune-related toxicities differ from traditional treatment-related adverse events
Why early medical involvement is critical throughout the trial lifecycle
Strategies for standardizing irAE grading and management across global sites
How central monitoring and site training can improve safety, retention, and data quality

Complete the form to watch the session on demand.

Watch the Webinar

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.